Bhupinder Kumar

3.1k total citations
93 papers, 2.3k citations indexed

About

Bhupinder Kumar is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Bhupinder Kumar has authored 93 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Organic Chemistry, 29 papers in Molecular Biology and 28 papers in Pharmacology. Recurrent topics in Bhupinder Kumar's work include Synthesis and biological activity (18 papers), Computational Drug Discovery Methods (17 papers) and Cholinesterase and Neurodegenerative Diseases (16 papers). Bhupinder Kumar is often cited by papers focused on Synthesis and biological activity (18 papers), Computational Drug Discovery Methods (17 papers) and Cholinesterase and Neurodegenerative Diseases (16 papers). Bhupinder Kumar collaborates with scholars based in India, Saudi Arabia and Taiwan. Bhupinder Kumar's co-authors include Vinod Kumar, Ashish Ranjan Dwivedi, Md Jawaid Akhtar, Vikramdeep Monga, Gurpreet Singh, Anil K. Mantha, Rohit Pal, Ramandeep Kaur, Rakesh Kumar and Ira Skvortsova and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Organic Chemistry and Molecules.

In The Last Decade

Bhupinder Kumar

82 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bhupinder Kumar India 30 1.3k 653 520 367 160 93 2.3k
Githa Elizabeth Mathew India 26 731 0.6× 443 0.7× 704 1.4× 271 0.7× 134 0.8× 48 1.7k
Saverio Cellamare Italy 29 747 0.6× 646 1.0× 515 1.0× 369 1.0× 181 1.1× 90 2.1k
Sinem Ilgın Türkiye 26 1.0k 0.8× 458 0.7× 476 0.9× 349 1.0× 129 0.8× 67 1.8k
Katarina Nikolić Serbia 23 689 0.5× 989 1.5× 651 1.3× 819 2.2× 179 1.1× 133 2.4k
Paweł Szymański Poland 20 424 0.3× 482 0.7× 448 0.9× 442 1.2× 138 0.9× 86 1.6k
Md Jawaid Akhtar India 26 901 0.7× 515 0.8× 210 0.4× 216 0.6× 145 0.9× 73 1.6k
Manjinder Singh India 21 751 0.6× 743 1.1× 642 1.2× 283 0.8× 102 0.6× 100 2.5k
Samuel Silvestre Portugal 26 850 0.7× 1.0k 1.6× 383 0.7× 179 0.5× 164 1.0× 86 2.6k
Óscar López Spain 25 1.4k 1.1× 842 1.3× 292 0.6× 130 0.4× 149 0.9× 116 2.5k
Síbel Süzen Türkiye 29 1.2k 0.9× 853 1.3× 222 0.4× 114 0.3× 129 0.8× 81 2.4k

Countries citing papers authored by Bhupinder Kumar

Since Specialization
Citations

This map shows the geographic impact of Bhupinder Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhupinder Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhupinder Kumar more than expected).

Fields of papers citing papers by Bhupinder Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhupinder Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhupinder Kumar. The network helps show where Bhupinder Kumar may publish in the future.

Co-authorship network of co-authors of Bhupinder Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Bhupinder Kumar. A scholar is included among the top collaborators of Bhupinder Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhupinder Kumar. Bhupinder Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Bhupinder, et al.. (2025). Emerging Research and Future Directions on Doxorubicin: A Snapshot. Asian Pacific Journal of Cancer Prevention. 26(1). 5–15. 3 indexed citations
2.
Choudhary, Diksha, Bhupinder Kumar, Balakumar Chandrasekaran, et al.. (2025). Microwave-Assisted Synthesis of Morpholine-Based Chalcones as Reversible MAO-A Inhibitors in the Management of Mental Depression. Pharmaceuticals. 18(3). 309–309. 2 indexed citations
3.
Bansal, Nisha, Ankita Dadwal, & Bhupinder Kumar. (2025). Key heterocyclic moieties for the next five years of drug discovery and development. Future Medicinal Chemistry. 17(22). 2657–2659.
4.
Choudhary, Diksha, Rajwinder Kaur, Balakumar Chandrasekaran, et al.. (2025). Exploring Phyto-Resources of Tulsi for the Management of Depression: A Discovery Through Computational and Pharmacological Studies. Chemistry Africa. 8(9). 4405–4419.
5.
Lakhanpal, Sorabh, et al.. (2024). Thieno[3,2-b]pyrrole as a privileged scaffold in medicinal chemistry: An exploration of synthetic strategies and anticancer attributes. Journal of Molecular Structure. 1321. 139654–139654. 2 indexed citations
6.
Joshi, Gaurav, et al.. (2024). Exploring the Insights on Exosomes and their Utility in Treating Ophthalmic Disease: Delving into the Clinical Approval and Present Trials. Current Drug Delivery. 23(1). 56–72. 1 indexed citations
7.
Choudhary, Diksha, Pooja A. Chawla, Rajwinder Kaur, et al.. (2024). Exploration of oxadiazole clubbed benzhydrylpiperazine pharmacophoric features as structural feature for antidepressant activity: In vitro, in vivo and in silico analysis. Bioorganic Chemistry. 144. 107148–107148. 5 indexed citations
8.
Gupta, P. K., et al.. (2023). Design, Synthesis, and Biological Evaluation of Novel Dihydropyrimidinone Derivatives as Potential Anticancer Agents and Tubulin Polymerization Inhibitors. Assay and Drug Development Technologies. 21(1). 17–28. 8 indexed citations
9.
Kumar, Bhupinder, et al.. (2023). Design, Synthesis, Molecular Docking, and Biological Evaluation of Isatin-Based Fused Heterocycles As Epidermal Growth Factor Receptor Inhibitors. Assay and Drug Development Technologies. 21(5). 222–233. 8 indexed citations
10.
Choudhary, Diksha, et al.. (2023). Design, synthesis and biological evaluation of oxadiazole clubbed piperazine derivatives as potential antidepressant agents. Bioorganic Chemistry. 136. 106544–106544. 15 indexed citations
11.
Dwivedi, Ashish Ranjan, et al.. (2023). A decade of USFDA-approved small molecules as anti-inflammatory agents: Recent trends and Commentaries on the “industrial” perspective. European Journal of Medicinal Chemistry. 263. 115942–115942. 6 indexed citations
12.
Kumar, Bhupinder, et al.. (2023). Impact of Microfluidic Chip Electrophoresis in Modern Analysis: AnUpdate on Recent Trends. Current Analytical Chemistry. 19(5). 358–373.
14.
Kumar, Bhupinder, et al.. (2022). Bioaccumulation of Heavy Metals in Squid (Loligo duvaucelii) from Tuticorin Coastal Waters. International Journal of Science and Research (IJSR). 11(12). 1095–1101. 1 indexed citations
15.
Kumar, Bhupinder, et al.. (2022). Nano Spray Dryer as an Advancement in Preparation of Nanoformulations:An Editorial. Current Analytical Chemistry. 18(10). 1037–1039.
16.
Kumar, Bhupinder, Ashish Ranjan Dwivedi, Tania Arora, et al.. (2022). Design, Synthesis, and Pharmacological Evaluation of N-Propargylated Diphenylpyrimidines as Multitarget Directed Ligands for the Treatment of Alzheimer’s Disease. ACS Chemical Neuroscience. 13(14). 2122–2139. 33 indexed citations
17.
18.
Dwivedi, Ashish Ranjan, et al.. (2020). Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Different Disease States: Recent Updates. Current Medicinal Chemistry. 28(16). 3193–3215. 40 indexed citations
19.
Kaur, Ramandeep, Bhupinder Kumar, Ashish Ranjan Dwivedi, & Vinod Kumar. (2016). Regioselective alkylation of 1,2,4-triazole using ionic liquids under microwave conditions. Green Processing and Synthesis. 5(3). 233–237. 7 indexed citations
20.
Kumar, Bhupinder, Virender Singh, Ravi Shankar, Kapil Kumar, & Ravindra K. Rawal. (2016). Synthetic and Medicinal Prospective of Structurally Modified Curcumins. Current Topics in Medicinal Chemistry. 17(2). 148–161. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026